To better compare belimumab’s efficacy with results from phase 3 trials of obinutuzumab, investigators conducted a post hoc analysis of patients with active proliferative lupus nephritis in the MMF ...

Patients who develop LN within 1 to 5 years after SLE onset may face poorer renal outcomes compared with those who develop the disease earlier.

A subset of patients receiving triple immunosuppressive therapy with voclosporin, mycophenolate mofetil, and low-dose glucocorticoids can achieve lower proteinuria targets.

Negotiated reliance may offer a way to provide care to patients who resist efforts by clinicians and healthcare facilities.

The FDA has approved HemiClor (12.5 mg chlorthalidone) tablets for the treatment of hypertension in adults, to lower blood pressure.

The FDA has granted Orphan Drug designation to NS-229 for the treatment of eosinophilic granulomatosis with polyangiitis.

The pledge comes as the United States plans to leave the international organization, The Washington Post reported.

Investigators aimed to identify an optimal PSA cut-off to define PSA persistence after prostate cancer surgery using new ultrasensitive assay methods.

These changes are meant to limit the use of the shots while experts collect more data on how well they work for healthy people.

Investigators present 48 month follow-up data from a phase 2b trial on padeliporfin vascular-targeted photodynamic therapy for intermediate-risk prostate cancer.

New research suggests that outpatients with cancer are more likely than other outpatients to have antimicrobial-resistant bacterial pathogens.

(HealthDay News) — Metabolic dysfunction-associated steatotic liver disease (MASLD) in pregnant women is a risk factor for preterm birth, according to a study published online May 9 in ...